NCT02155595View on ClinicalTrials.gov

Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy

CompletedOBSERVATIONAL
Enrollment

738

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
OsteoporosisAtypical Femoral FracturesProdromal Bone Deterioration
Interventions
OTHER

500 without BP treatment

lab tests, X-ray, bone scan or MRI, as needed

OTHER

500 with BP treatment

lab tests, X-ray, bone scan or MRI, as needed (90 of these individuals can opt for iliac crest bone biopsy)

Trial Locations (1)

48202

Henry Ford Medical Center, New Center One, Detroit

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Henry Ford Health System

OTHER

NCT02155595 - Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy | Biotech Hunter | Biotech Hunter